Trusted brands in one place
Clinically proven for weight loss
Doctor-guided programs
No in-person appointments needed
Trusted brands in one place
Clinically proven for weight loss
Doctor-guided programs
No in-person appointments needed

Explore GLP-1's
News & Updates

Learn more about GLP'-1's latest news & updates

Explore By Category

All
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
GLP-1s and Unexpected Pregnancy: What to Know
Women's Health

GLP-1s and Unexpected Pregnancy: What to Know

GLP-1 medications like semaglutide and tirzepatide are known for weight loss, but researchers are now raising concerns about an unexpected side effect: increased fertility. Women on these drugs may become pregnant without realizing their risk has changed. Here's what you need to know before starting or continuing treatment.

Read More
GLP-1 Side Effects: What You Need to Know
Side Effects & Safety

GLP-1 Side Effects: What You Need to Know

GLP-1 medications like Wegovy, Mounjaro, and Ozempic can cause a range of side effects, from mild nausea to rarer serious complications. This guide covers what to expect, how to manage common symptoms, and red flags that should prompt a call to your doctor.

Read More
GLP-1s and Your Love Life: What to Expect
Health and Wellness

GLP-1s and Your Love Life: What to Expect

GLP-1 medications like semaglutide and tirzepatide are reshaping bodies across the country, but the ripple effects extend far beyond the scale. From renewed confidence to unexpected relationship friction, here is what patients are actually experiencing in their personal lives and what the research suggests so far.

Read More
Shindong Lost 37 kg on Wegovy: What It Means for You
Patient Guides

Shindong Lost 37 kg on Wegovy: What It Means for You

Super Junior's Shindong made headlines after losing 37 kg in five months on Wegovy and then stopping the medication. His story raises real questions about semaglutide results, the "obesity gene," and what happens when you discontinue GLP-1 treatment.

Read More
Why You Might Be Denied a GLP-1 Drug
News & Updates

Why You Might Be Denied a GLP-1 Drug

Millions of people qualify for GLP-1 medications on paper, but a growing number are hitting roadblocks when they try to actually get them. From insurance denials to pharmacy shortages and prior authorization battles, here is what is standing between patients and their prescriptions, and what you can do about it.

Read More
Oral GLP-1s and Brain Food Cravings: What We Know
Patient Guides

Oral GLP-1s and Brain Food Cravings: What We Know

Emerging research suggests oral GLP-1 medications may reduce food cravings by acting directly on the brain's reward and appetite circuits. This could reshape how patients and providers think about pill-based alternatives to injectable GLP-1 drugs. Here's what the science shows and what it means for you.

Read More
GLP-1 Weight Loss and Marriage Rates: What the Research Shows
Weight Loss

GLP-1 Weight Loss and Marriage Rates: What the Research Shows

A Harvard study found a notable increase in marriage rates among women who lost significant weight. We break down what the research actually says, what it doesn't, and what it means for people using GLP-1 medications like semaglutide and tirzepatide.

Read More
Ozempic Effect Without a Needle: What Works?
Patient Guides

Ozempic Effect Without a Needle: What Works?

Millions of people want the appetite-suppressing, blood sugar-stabilizing benefits of Ozempic without the weekly injection. This article breaks down what needle-free alternatives actually exist, what the science supports, and how to think through your options with a doctor.

Read More
GLP-1 Drugs May Cut Long-Term Sick Leave
Health and Wellness

GLP-1 Drugs May Cut Long-Term Sick Leave

Emerging research suggests GLP-1 medications may do more than reduce weight. They could also significantly cut long-term sick leave, with implications for patients, employers, and insurance coverage decisions. Here's what the evidence shows and what it means for you.

Read More